Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Screening for Frailty in Older Patients With Early-Stage Solid Tumors: A Prospective Longitudinal Evaluation of Three Different Geriatric Tools.
Biganzoli L, Mislang AR, Di Donato S, Becheri D, Biagioni C, Vitale S, Sanna G, Zafarana E, Gabellini S, Del Monte F, Mori E, Pozzessere D, Brunello A, Luciani A, Laera L, Boni L, Di Leo A, Mottino G. Biganzoli L, et al. Among authors: gabellini s. J Gerontol A Biol Sci Med Sci. 2017 Jul 1;72(7):922-928. doi: 10.1093/gerona/glw234. J Gerontol A Biol Sci Med Sci. 2017. PMID: 28158486
Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy.
Bonechi M, Galardi F, Biagioni C, De Luca F, Bergqvist M, Neumüller M, Guarducci C, Boccalini G, Gabellini S, Migliaccio I, Di Leo A, Pestrin M, Malorni L. Bonechi M, et al. Among authors: gabellini s. Oncotarget. 2018 Mar 27;9(23):16389-16399. doi: 10.18632/oncotarget.24700. eCollection 2018 Mar 27. Oncotarget. 2018. PMID: 29662653 Free PMC article.
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial.
Galardi F, De Luca F, Biagioni C, Migliaccio I, Curigliano G, Minisini AM, Bonechi M, Moretti E, Risi E, McCartney A, Benelli M, Romagnoli D, Cappadona S, Gabellini S, Guarducci C, Conti V, Biganzoli L, Di Leo A, Malorni L. Galardi F, et al. Among authors: gabellini s. Breast Cancer Res. 2021 Mar 24;23(1):38. doi: 10.1186/s13058-021-01415-w. Breast Cancer Res. 2021. PMID: 33761970 Free PMC article. Clinical Trial.
Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial.
Livraghi L, Martella F, Ghilli M, Angiolini C, Magnanini S, Moretti E, Bengala C, Risi E, Molinara E, Pazzagli I, Malorni L, Donati S, Gabellini S, Martignetti A, Giannessi P, Sanna G, Barellini L, Biagioni C, Boni L, Bianchi S, Roncella M, Biganzoli L. Livraghi L, et al. Among authors: gabellini s. Eur J Cancer. 2024 Dec;213:115108. doi: 10.1016/j.ejca.2024.115108. Epub 2024 Oct 31. Eur J Cancer. 2024. PMID: 39522332 Free article.
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.
Frezza AM, Leonard H, Aggerholm-Pedersen N, Badalamenti G, Baili P, Baldi GG, Bauer S, Bazzurri S, Benzonelli I, Bertuzzi A, Blay JY, Bianchi G, Bonfarnuzzo S, Bouvier C, Boye K, Martin Broto J, Brunello A, Campanacci D, Casali PG, Cicala C, Crotti E, D'Ambrosio L, Dei Tos AP, Dieckmann N, Dufresne A, Elston S, Ferraresi V, Gabellini S, Giani C, Giannusa V, Gil Sanjines M, Grassani T, Gronchi A, Lasalvia P, Lindskog S, Hindi N, Ingrosso M, Ivanescu A, Jones R, Lugowska I, Ketzer J, Mariuk-Jarema A, Mazzocca A, Monteleone L, Morosi C, Napolitano A, Nardozza F, Neri E, Nilsson M, Papakonstantinou A, Pasquali S, Sbaraglia M, Scolari F, Szkandera J, Valverde C, Vincenzi B, Vizzaccaro S, Zuccheri F, Stacchiotti S, Trama A. Frezza AM, et al. Among authors: gabellini s. PLoS One. 2024 Aug 12;19(8):e0308387. doi: 10.1371/journal.pone.0308387. eCollection 2024. PLoS One. 2024. PMID: 39133752 Free PMC article.
11 results